Brenda Libby Coleman

Array ( [id] => 10182499 [patent_doc_number] => 09212172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-15 [patent_title] => 'Preparation of crystalline bazedoxifene and its salts' [patent_app_type] => utility [patent_app_number] => 13/822519 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11129 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13822519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113309 [patent_doc_number] => 08569483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Process for the preparation of bazedoxifene acetate and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 13/227898 [patent_app_country] => US [patent_app_date] => 2011-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4779 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13227898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11211920 [patent_doc_number] => 09440948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-13 [patent_title] => 'Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use' [patent_app_type] => utility [patent_app_number] => 13/819067 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 22806 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9512100 [patent_doc_number] => 20140148593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'PROCESS FOR PREPARING FLUTICASONE PROPIONATE/FUROATE' [patent_app_type] => utility [patent_app_number] => 13/820124 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6748 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162092 [patent_doc_number] => 20130310369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'SALTS OF LORCASERIN WITH OPTICALLY ACTIVE ACIDS' [patent_app_type] => utility [patent_app_number] => 13/820126 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 36813 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662211 [patent_doc_number] => 20110311480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/222256 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41541 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311480.pdf [firstpage_image] =>[orig_patent_app_number] => 13222256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854379 [patent_doc_number] => 20130144054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'NOVEL PRODUCTION METHOD FOR ISOQUINOLINE DERIVATIVES AND SALTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/816534 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11367 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8940693 [patent_doc_number] => 20130190490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'PROCESS FOR PREPARING TOLVAPTAN INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 13/877962 [patent_app_country] => US [patent_app_date] => 2010-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3003 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784716 [patent_doc_number] => 20120046272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'Novel Therapeutic Compounds' [patent_app_type] => utility [patent_app_number] => 13/213672 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6280 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046272.pdf [firstpage_image] =>[orig_patent_app_number] => 13213672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211364 [patent_doc_number] => 20120129833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'CYCLIC KETOENOLS FOR THERAPY' [patent_app_type] => utility [patent_app_number] => 13/213436 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38027 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129833.pdf [firstpage_image] =>[orig_patent_app_number] => 13213436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001390 [patent_doc_number] => 09045468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => '2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin' [patent_app_type] => utility [patent_app_number] => 13/211678 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53572 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13211678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778942 [patent_doc_number] => 20120041193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'SUBSTITUTED INTERNAL VINYL-BORONIC ACIDS AND BORONIC ACID DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/207327 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13634 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041193.pdf [firstpage_image] =>[orig_patent_app_number] => 13207327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580909 [patent_doc_number] => 20110294792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'PURINE DERIVATIVES AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/206057 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59650 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294792.pdf [firstpage_image] =>[orig_patent_app_number] => 13206057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932839 [patent_doc_number] => 08492541 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-07-23 [patent_title] => 'Synthesis of azido heterocycles' [patent_app_type] => utility [patent_app_number] => 13/197276 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2347 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13197276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549319 [patent_doc_number] => 08324201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Pyrazinooxazepine derivatives' [patent_app_type] => utility [patent_app_number] => 13/192865 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55134 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13192865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756858 [patent_doc_number] => 20120028961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => '6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist' [patent_app_type] => utility [patent_app_number] => 13/192707 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 163415 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028961.pdf [firstpage_image] =>[orig_patent_app_number] => 13192707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587544 [patent_doc_number] => 20110282054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'PYRAZINOOXAZEPINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/192845 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55088 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20110282054.pdf [firstpage_image] =>[orig_patent_app_number] => 13192845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8830290 [patent_doc_number] => 20130131335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'METHODS FOR THE PREPARATION OF DROSPIRENONE AND INTERMEDIATES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/813195 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7098 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842051 [patent_doc_number] => 20130137679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'Novel Functionally Selective Ligands of Dopamine D2 Receptors' [patent_app_type] => utility [patent_app_number] => 13/807347 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 36521 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511452 [patent_doc_number] => 20110257162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'HIV INTEGRASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/172393 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45243 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257162.pdf [firstpage_image] =>[orig_patent_app_number] => 13172393 [rel_patent_id] =>[rel_patent_doc_number] =>)